Loading organizations...

§ Private Profile · Seattle, WA, USA
Medical device developer creating mobility devices for individuals with impairments, using Exotendon for walking recovery.
Based in Seattle, Washington, Cadence Biomedical develops specialized medical devices designed to improve mobility and assist walking recovery for stroke survivors and individuals with severe neurological conditions. The company's primary product, Kickstart, utilizes a proprietary pulley-and-spring system called Exotendon to facilitate physical rehabilitation without requiring external motors or battery power. To support the ongoing commercialization, sales expansion, and clinical development of its rehabilitation technology, the enterprise has secured multiple rounds of financing, including a $1.1 million funding round in 2012 and a subsequent $1.2 million Series B round in 2015. Cadence Biomedical has received institutional financial backing from venture capital firms such as HealthTech Capital, BioPacific Investments, and Frontier Angel Fund, alongside a $1 million research grant from the Department of Defense. The organization was originally established in 2007 by founder and chief operating officer Brian Glaister.
Cadence Biomedical has raised $4.6M across 4 funding rounds.
Cadence Biomedical has raised $4.6M in total across 4 funding rounds.
Cadence Biomedical has raised $4.6M across 4 funding rounds. Most recently, it raised $1.2M Series B in June 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 24, 2015 | $1.2M Series B | HealthTech Capital | BioPacific Investors, Frontier Angels | Announced |
| May 30, 2013 | $1M Grant | — | — | Announced |
| Apr 12, 2013 | $1.3M Venture Round | — | — | Announced |
| Apr 26, 2012 | $1.1M Series A | Donna Jang | ACE Fund, Alliance OF Angels, Frontier Angels, Keiretsu Forum Northwest, Sand Hill Angels, Tech Coast Angels, Wing Venture Capital | Announced |
Cadence Biomedical has raised $4.6M in total across 4 funding rounds.
Cadence Biomedical's investors include HealthTech Capital, BioPacific Investors, Frontier Angels, Donna Jang, ACE Fund, Alliance of Angels, Keiretsu Forum Northwest, Sand Hill Angels, Tech Coast Angels, Wing Venture Capital.